MedPath

YSOPIA Bioscience

YSOPIA Bioscience logo
🇫🇷France
Ownership
Private
Established
2010-01-01
Employees
11
Market Cap
-
Website
https://ysopia.bio

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults

Phase 1
Completed
Conditions
Obesity
Metabolic Disease
Interventions
Drug: Placebo
First Posted Date
2020-12-10
Last Posted Date
2021-07-13
Lead Sponsor
YSOPIA Bioscience
Target Recruit Count
38
Registration Number
NCT04663139
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.